Nyman, U.; Aspelin, P.
Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949. Children 2022, 9, 696.
https://doi.org/10.3390/children9050696
AMA Style
Nyman U, Aspelin P.
Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949. Children. 2022; 9(5):696.
https://doi.org/10.3390/children9050696
Chicago/Turabian Style
Nyman, Ulf, and Peter Aspelin.
2022. "Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949" Children 9, no. 5: 696.
https://doi.org/10.3390/children9050696
APA Style
Nyman, U., & Aspelin, P.
(2022). Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949. Children, 9(5), 696.
https://doi.org/10.3390/children9050696